The Bleeding Edge

No detailed brain note yet for The Bleeding Edge. USPs will populate as FID mines its promos.

No analyzed promos yet.

• 2026-07-02EDITORIALThe Bleeding Edge
  A Golden Age of Supersonic Travel
  Jeff Brown analyzes the history of supersonic commercial aviation (Concorde, Boeing Sonic Cruiser) and frames the current regulatory shift toward allowing supersonic flight over land as the beginning of a 'Golden Age of Travel' driven by American innovation. The email promotes an upcoming replay of a Biotech Moment event while positioning supersonic travel infrastructure as an emerging investment theme.
• 2026-07-01EDITORIALThe Bleeding Edge
  The Next Generation of Medical Imaging
  Jeff Brown analyzes Midjourney Medical's new full-body ultrasound scanner as a potential 50-year breakthrough in medical imaging, powered by AI and semiconductor transducer technology. The email promotes Brown's live 'Biotech Moment' event covering biotech sector recovery driven by AI innovation and investment strategy.
• 2026-06-30EDITORIALThe Bleeding Edge
  Are We in a Simulation?
  Jeff Brown explores simulation theory and whether our reality is a computational simulation hosted by an advanced civilization, contextualizing the theory through science fiction and philosopher Nick Bostrom's 2003 paper. The email promotes an upcoming 8 p.m. ET presentation on biotech industry convergence and a strategy to capitalize on a coming 'golden age of biotech.'
• 2026-06-29EDITORIALThe Bleeding Edge
  The Remarkable Success of the Reactor Pilot Program
  Jeff Brown analyzes the DOE's Reactor Pilot Program success in advancing fourth-generation nuclear fission technology, highlighting the ambitious July 4 deadline (250th Declaration of Independence anniversary) for three advanced reactors to achieve criticality under Executive Order 14301. The email covers the 10 companies and 11 projects selected for the program, positioning nuclear power as a critical infrastructure play amid a broader 'golden age of biotech' narrative promoted in an upcoming live event.
• 2026-06-26EDITORIALThe Bleeding Edge
  Will Musk Turn to Small Modular Reactors?
  Jeff Brown provides an AMA segment analyzing whether Elon Musk will partner with X-Energy for small modular reactor technology to power his mega-factories supporting SpaceX and xAI. The email discusses X-Energy's IPO performance and Amazon's investment rationale, positioning nuclear fission technology as a solution to the AI energy bottleneck.
• 2026-06-25EDITORIALThe Bleeding Edge
  The Other D.C. Cage Match
  Ben Lilly analyzes the regulatory conflict between CFTC Chairman Mike Selig and CME CEO Terry Duffy over Kalshi and Coinbase's new perpetual futures offerings to retail investors. The email frames this as a significant market development that opened up $90 trillion in annual crypto derivatives volume to U.S. traders for the first time. The piece also promotes Jeff Brown's upcoming Biotech Moment event featuring an AI trading system.
• 2026-06-25PROMOThe Bleeding Edge
  Important Details About Biotech
  Jeff Brown promotes 'The Biotech Moment' event (July 1, 8 PM ET) claiming biotech is entering a 'golden age' with 25%-850% gains in hours. Pitches $4,000/month average returns for four years if readers register before July 23 deadline. Registration link included; no specific ticker disclosed.
• 2026-06-24EDITORIALThe Bleeding Edge
  Signs of Recovery in the Biotech Industry
  The Bleeding Edge editorial analyzes recovery signals in the biotechnology sector over the past six months, featuring Parabilis Medicines' successful $745M IPO/partnership as evidence of renewed investor confidence. Jeff Brown is promoting a live event next Wednesday (8 p.m. ET) to discuss biotech industry convergence and his strategy for capitalizing on the recovery.